Little Green Pharma Sells WA Facility for $7.8M to Fund European Expansion
Little Green Pharma is a pioneering medicinal cannabis company dedicated to providing natural health solutions with a global footprint. Operating from state-of-the-art facilities in Denmark and Australia, the company focuses on developing innovative, high-quality cannabis-based products that offer alternative therapeutic options for patients. Their commitment to responsible manufacturing and cutting-edge research sets them apart in the rapidly evolving medicinal cannabis industry.
The company has established itself as a leader in the European and Australian natural health sectors by prioritizing ethical clinical research and sustainable business practices. Little Green Pharma supports comprehensive scientific studies to better understand alternative therapies, including one of the largest longitudinal studies of its kind in Australia. Their approach goes beyond product development, emphasizing collaboration with industry innovators and a holistic view of health that encompasses economic vitality, environmental sustainability, and societal well-being.
Sustainability and social responsibility are core to Little Green Pharma’s mission. They have created a dedicated Green Committee to ensure their operations positively impact both society and the environment. By focusing on principles like access, inclusion, and ethical capacity, the company aims to make natural health products more accessible and affordable. Their commitment to innovation, quality, and responsible practices positions them as a forward-thinking organization that is not just producing medicinal cannabis, but actively working to transform perceptions and improve patient care in the natural health landscape.